Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

General Counsel and Secretary

President and COO

Chief Executive Officer

Chief Financial Officer

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-07	Premium	acquired	Premium	Premium	Premium	General Counsel and Secretary
2024-05-07	Premium	acquired	Premium	Premium	Premium	President and COO
2024-05-07	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-05-07	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-15	Premium	sold	Premium	Premium	Premium	-
2024-01-26	Premium	acquired	Premium	Premium	Premium	-
2023-09-26	Premium	sold	Premium	Premium	Premium	-
2023-09-25	Premium	sold	Premium	Premium	Premium	-
2023-09-21	Premium	sold	Premium	Premium	Premium	-
2023-09-20	Premium	sold	Premium	Premium	Premium	-
2022-11-30	Premium	acquired	Premium	Premium	Premium	-
2022-11-30	Premium	acquired	Premium	Premium	Premium	-
2022-09-20	Premium	sold	Premium	Premium	Premium	-
2022-01-07	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-01-07	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2021-10-18	Premium	acquired	Premium	Premium	Premium	-
2021-10-18	Premium	bought	Premium	Premium	Premium	-

LUCD - Lucid Diagnostics Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for LUCD